Haemonetics | HAE - Equity Capital And Reserves


Haemonetics reported $837.1M in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Baxter International USD 6.21B 163M Jun/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Boston Scientific USD 24.93B 934M Jun/2026
Cerus USD 64.22M 2.76M Dec/2025
Cooper Companies USD 8.36B 124.7M Dec/2025
Fresenius EUR 19.7B 766M Jun/2026
Fresenius Medical Care EUR 13.53B 673.44M Jun/2026
Globus Medical USD 4.77B 36.29M Jun/2026
Haemonetics USD 837.1M 40.78M Jun/2026
ICU Medical USD 2.15B 39.92M Jun/2026
Intuitive Surgical USD 18.17B 693.9M Jun/2026
Medtronic USD 50.07B 1.09B Mar/2026
Merit Medical Systems USD 1.68B 53.08M Jun/2026
Neogen USD 2.09B 9.5M Mar/2026
OraSure Technologies USD 317.78M 4.45M Jun/2026
Plus Therapeutics USD 5.46M 6.5M Jun/2026
Quidel USD 1.85B 69.1M Mar/2026
ResMed USD 6.59B 93.48M Jun/2026
STAAR Surgical USD 365.4M 13.03M Jun/2026
Steris USD 7.21B 23.1M Jun/2026
Stryker USD 22.98B 559M Mar/2026
Teleflex USD 2.9B 179.9M Jun/2026
Terumo JPY 1.66T 77.51B Jun/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
US Physical Therapy USD 448.66M 20.32M Jun/2026
Zimmer Biomet Holdings USD 12.63B 49.1M Jun/2026